Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular medicine (Berlin, Germany) Vol. 87; no. 8; pp. 803 - 813
Main Authors Catalán, V., Gómez-Ambrosi, J., Rodríguez, A., Ramírez, B., Silva, C., Rotellar, F., Gil, M. J., Cienfuegos, J. A., Salvador, J., Frühbeck, G.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.08.2009
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0946-2716
1432-1440
DOI10.1007/s00109-009-0486-8

Cover

Loading…
Abstract Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA ( p  < 0.0001) and protein ( p  = 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found ( p  = 0.038) in the obese group. Moreover, obese individuals showed increased ( p  < 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation ( p  < 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers ( p  < 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.
AbstractList Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (p < 0.0001) and protein (p = 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (p = 0.038) in the obese group. Moreover, obese individuals showed increased (p < 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (p < 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (p < 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.
Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (p<0.0001) and protein (p=0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (p=0.038) in the obese group. Moreover, obese individuals showed increased (p<0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (p<0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (p<0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.[PUBLICATION ABSTRACT]
Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA ( p  < 0.0001) and protein ( p  = 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found ( p  = 0.038) in the obese group. Moreover, obese individuals showed increased ( p  < 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation ( p  < 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers ( p  < 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.
Author Catalán, V.
Ramírez, B.
Silva, C.
Rotellar, F.
Cienfuegos, J. A.
Gil, M. J.
Salvador, J.
Gómez-Ambrosi, J.
Rodríguez, A.
Frühbeck, G.
Author_xml – sequence: 1
  givenname: V.
  surname: Catalán
  fullname: Catalán, V.
  organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 2
  givenname: J.
  surname: Gómez-Ambrosi
  fullname: Gómez-Ambrosi, J.
  organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 3
  givenname: A.
  surname: Rodríguez
  fullname: Rodríguez, A.
  organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 4
  givenname: B.
  surname: Ramírez
  fullname: Ramírez, B.
  organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 5
  givenname: C.
  surname: Silva
  fullname: Silva, C.
  organization: Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 6
  givenname: F.
  surname: Rotellar
  fullname: Rotellar, F.
  organization: Department of Surgery, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 7
  givenname: M. J.
  surname: Gil
  fullname: Gil, M. J.
  organization: Department of Biochemistry, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 8
  givenname: J. A.
  surname: Cienfuegos
  fullname: Cienfuegos, J. A.
  organization: Department of Surgery, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 9
  givenname: J.
  surname: Salvador
  fullname: Salvador, J.
  organization: Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
– sequence: 10
  givenname: G.
  surname: Frühbeck
  fullname: Frühbeck, G.
  email: gfruhbeck@unav.es
  organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21766997$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19466389$$D View this record in MEDLINE/PubMed
BookMark eNqFkstu1TAQhi1URC_wAGyQhQS7gJ04drxEFZdKldjA2nKcCbhy7IPHQe378KA4PYciFQELy9bM98_FM6fkKKYIhDzl7BVnTL1GxjjTDduOGGQzPCAnXHRtw4VgR-SEaSGbVnF5TE4Rryqtei0ekWNeHbIb9An5cRFdBoswUTv5XUKgxSOuQOF6lwHRp0jTTEP1ORt8bFrqq2UE9OWGeqQZgi1VXlJ1zMEuiy2byMaJ1mf213SBYkNIu5wK-FiT1SC37j_smlpX_HdfPOCW5-u62IiPycPZBoQnh_uMfH739tP5h-by4_uL8zeXjRNalsaOvXNtJ50eeuBu7PSk1cy61nZM9TCNjsGkRhhhsKPrpWSd7h0Ip6d5mjl0Z-TlPm6t6NsKWMzi0UEINkJa0UglZP04_l-wZVxI1rIKPr8HXqU1x9qEabmSgxCyq9CzA7SOC0xml_1i8435NaUKvDgAFusQ5myj83jHbZGk1qpyas-5nBAzzMb5cjuNkq0PhjOz7Y3Z741h26l7Y4aq5PeUd0X8Q9PuNVjZ-AXy797-LvoJ4U_YQg
CitedBy_id crossref_primary_10_1017_S095442241400002X
crossref_primary_10_26508_lsa_202302228
crossref_primary_10_1016_j_biopha_2022_112879
crossref_primary_10_1152_ajpendo_00297_2015
crossref_primary_10_1210_en_2011_1642
crossref_primary_10_1016_j_molmet_2013_04_003
crossref_primary_10_1159_000337604
crossref_primary_10_3390_cancers14071679
crossref_primary_10_1177_1099800411410870
crossref_primary_10_1111_obr_12377
crossref_primary_10_1002_oby_22254
crossref_primary_10_1038_s41467_021_27734_2
crossref_primary_10_1016_j_diabres_2014_01_014
crossref_primary_10_1093_carcin_bgw050
crossref_primary_10_3390_ijms221910460
crossref_primary_10_1016_j_plipres_2010_10_005
crossref_primary_10_3390_ijerph182413333
crossref_primary_10_3389_fimmu_2022_935275
crossref_primary_10_1016_j_cyto_2011_07_021
crossref_primary_10_3390_jcm8060854
crossref_primary_10_1080_14737159_2023_2215928
crossref_primary_10_1074_jbc_M115_685644
crossref_primary_10_3389_fcvm_2020_583175
crossref_primary_10_1016_j_biochi_2022_09_003
crossref_primary_10_3390_metabo11020070
crossref_primary_10_1039_C7MT00241F
crossref_primary_10_1016_j_metabol_2023_155527
crossref_primary_10_1016_j_peptides_2019_170117
crossref_primary_10_1007_s11695_013_1111_z
crossref_primary_10_1007_s00592_012_0399_9
crossref_primary_10_1152_physiol_00037_2018
crossref_primary_10_1016_j_molmet_2023_101763
crossref_primary_10_1186_1471_230X_13_120
crossref_primary_10_1530_JOE_18_0314
crossref_primary_10_1002_biof_1628
crossref_primary_10_1002_oby_20507
crossref_primary_10_1038_s41598_020_71109_4
crossref_primary_10_1016_j_mce_2019_04_002
crossref_primary_10_1210_endocr_bqaa149
crossref_primary_10_1089_ten_tea_2017_0384
crossref_primary_10_1172_jci_insight_122289
crossref_primary_10_1111_j_1476_5381_2011_01528_x
crossref_primary_10_3390_ijms17122125
crossref_primary_10_1055_a_1849_6707
crossref_primary_10_1371_journal_pone_0098398
crossref_primary_10_1155_2013_204164
crossref_primary_10_3390_nu14235049
crossref_primary_10_1007_s00266_021_02649_x
crossref_primary_10_1096_fj_201600787rr
crossref_primary_10_2174_1874288201812010089
crossref_primary_10_1016_j_mce_2016_03_011
crossref_primary_10_21518_2079_701X_2022_16_6_264_272
crossref_primary_10_1155_2011_587495
crossref_primary_10_1186_1476_9255_9_35
crossref_primary_10_1055_a_1909_1922
crossref_primary_10_3390_jcm9041069
crossref_primary_10_1016_j_jnutbio_2010_04_015
crossref_primary_10_1016_j_pharma_2012_10_003
crossref_primary_10_1016_j_jdermsci_2020_06_008
crossref_primary_10_1016_j_endmts_2020_100061
crossref_primary_10_1038_oby_2011_61
crossref_primary_10_3390_rheumato4040016
crossref_primary_10_1007_s13105_016_0547_8
crossref_primary_10_1016_j_pan_2020_01_002
crossref_primary_10_1007_s12263_013_0380_4
crossref_primary_10_1530_EJE_11_0660
crossref_primary_10_1038_nrrheum_2011_107
crossref_primary_10_1186_s12944_022_01622_0
crossref_primary_10_1007_s11695_014_1407_7
crossref_primary_10_1016_j_jff_2016_06_026
crossref_primary_10_1016_j_clinre_2024_102336
crossref_primary_10_1152_physiolgenomics_00039_2012
crossref_primary_10_3389_fendo_2018_00167
crossref_primary_10_3390_ijms19113331
crossref_primary_10_1038_s41537_019_0075_y
crossref_primary_10_3109_10715762_2015_1134795
crossref_primary_10_3109_14767058_2010_487138
crossref_primary_10_3389_fonc_2020_605097
crossref_primary_10_1631_jzus_B1600383
crossref_primary_10_1007_s11357_021_00322_4
crossref_primary_10_1155_2017_9039302
crossref_primary_10_1210_endocr_bqz010
crossref_primary_10_1038_s41392_023_01376_w
crossref_primary_10_2147_DMSO_S338254
crossref_primary_10_1007_s00394_012_0464_8
crossref_primary_10_1161_HYPERTENSIONAHA_115_05431
crossref_primary_10_1016_j_pneurobio_2015_06_005
crossref_primary_10_1152_ajpheart_00907_2011
crossref_primary_10_3390_nu12051305
crossref_primary_10_2337_dc11_s238
crossref_primary_10_1016_j_nut_2015_01_009
crossref_primary_10_1096_fj_202101105R
crossref_primary_10_3390_biom11070921
crossref_primary_10_1016_j_gene_2024_148766
crossref_primary_10_1097_MD_0000000000004039
crossref_primary_10_7570_kjo_2014_23_4_222
crossref_primary_10_1016_j_jss_2012_05_008
crossref_primary_10_1016_j_arr_2021_101414
crossref_primary_10_1021_bi201115q
crossref_primary_10_1016_j_atherosclerosis_2018_06_015
crossref_primary_10_1136_ard_2010_132399
crossref_primary_10_1007_s11695_019_03914_4
crossref_primary_10_1111_j_1440_1681_2011_05557_x
crossref_primary_10_1155_2010_784343
crossref_primary_10_1016_j_bcp_2019_113626
crossref_primary_10_1159_000444855
crossref_primary_10_18632_oncotarget_14589
crossref_primary_10_1016_j_canlet_2011_11_002
crossref_primary_10_1111_jgh_12597
crossref_primary_10_1016_j_jnutbio_2012_12_005
crossref_primary_10_1016_j_peptides_2017_03_001
crossref_primary_10_1111_bcpt_13332
crossref_primary_10_1074_jbc_M113_532234
crossref_primary_10_1111_eci_12649
crossref_primary_10_1371_journal_pone_0048612
crossref_primary_10_1007_s11010_016_2857_0
crossref_primary_10_1016_j_biochi_2012_12_014
crossref_primary_10_1158_0008_5472_CAN_16_1986
crossref_primary_10_1080_00207454_2017_1349766
crossref_primary_10_1074_jbc_M110_123331
crossref_primary_10_1111_j_1476_5381_2011_01587_x
crossref_primary_10_3892_mmr_2024_13329
crossref_primary_10_1016_j_molmet_2019_09_009
crossref_primary_10_1038_ijo_2013_199
crossref_primary_10_1111_jdv_13701
crossref_primary_10_1016_S2468_1253_16_30106_6
crossref_primary_10_1186_s12974_024_03104_9
crossref_primary_10_2337_db09_1541
crossref_primary_10_1038_s41419_023_06160_w
crossref_primary_10_1161_HYPERTENSIONAHA_111_187872
crossref_primary_10_1007_s00105_024_05306_x
crossref_primary_10_2337_dc14_0937
crossref_primary_10_1146_annurev_nutr_071816_064559
crossref_primary_10_1080_08037051_2016_1249336
crossref_primary_10_1038_s41419_021_03512_2
crossref_primary_10_1007_s12263_015_0460_8
crossref_primary_10_2147_BCTT_S491277
crossref_primary_10_3390_ijms22062865
crossref_primary_10_1017_S0954422412000145
crossref_primary_10_1038_nri2921
crossref_primary_10_3390_ijms21155529
crossref_primary_10_1152_physiolgenomics_00118_2019
crossref_primary_10_1155_2019_8171373
crossref_primary_10_3390_ijms22041667
crossref_primary_10_4236_jdm_2011_14012
crossref_primary_10_1111_eci_12997
crossref_primary_10_1089_met_2024_0099
crossref_primary_10_1016_j_bbadis_2013_05_006
crossref_primary_10_1016_j_tem_2017_01_003
crossref_primary_10_1038_s41574_019_0246_y
crossref_primary_10_1111_1346_8138_13227
Cites_doi 10.2337/dc08-1236
10.1055/s-2002-38256
10.1097/01.hjh.0000239295.17636.6e
10.1038/oby.2005.146
10.1038/nature05488
10.1016/j.metabol.2008.02.019
10.1111/j.1467-789X.2007.00316.x
10.1161/01.RES.0000227550.00426.60
10.1096/fj.00-0829hyp
10.1210/me.2007-0420
10.1053/j.gastro.2007.03.059
10.1074/jbc.270.38.22565
10.1074/jbc.M107101200
10.2337/db07-0007
10.1111/j.1600-6143.2006.01723.x
10.1111/j.1365-2265.2007.03156.x
10.2337/diabetes.47.9.1384
10.1210/jc.2007-0349
10.1002/jcb.21980
10.1007/s11695-008-9424-z
10.1002/path.1400
10.1038/nature05487
10.1038/nature03104
10.2337/diabetes.50.9.2080
10.1126/science.7678183
10.1016/j.cmet.2007.04.006
10.1007/978-1-59745-245-8_1
10.1038/nature03711
10.1053/j.gastro.2007.03.058
10.1016/0014-5793(92)81511-J
10.1055/s-2007-982502
10.1074/jbc.M103334200
10.1126/science.1061075
10.1074/jbc.M106089200
10.2174/138161207781039599
10.1373/clinchem.2006.075614
10.1016/j.cell.2005.10.027
10.1016/j.tcb.2005.12.005
10.1016/j.febslet.2004.12.031
10.1093/ajcn/83.2.461S
10.1111/j.1365-2265.2007.03021.x
10.1038/bjc.1996.374
10.1007/s00125-003-1053-4
10.1096/fj.03-0591fje
10.1172/JCI23056
10.1160/TH07-10-0589
10.1152/ajpendo.2001.280.6.E827
ContentType Journal Article
Copyright Springer-Verlag 2009
2009 INIST-CNRS
Copyright_xml – notice: Springer-Verlag 2009
– notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7TS
7X8
DOI 10.1007/s00109-009-0486-8
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Physical Education Index
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Physical Education Index
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Physical Education Index
ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central (NC Live)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1440
EndPage 813
ExternalDocumentID 1966527461
19466389
21766997
10_1007_s00109_009_0486_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7R
Z7U
Z7W
Z7Z
Z82
Z83
Z87
Z8M
Z8O
Z8Q
Z8T
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ADHKG
AFDZB
AFOHR
AGQPQ
AHPBZ
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7TS
PUEGO
7X8
ID FETCH-LOGICAL-c496t-ab5cc236c985e1cb39d97f032a3075edbc0ed7bebe8abc5660395ce4c9dfdf1e3
IEDL.DBID 7X7
ISSN 0946-2716
IngestDate Mon Jul 21 09:41:24 EDT 2025
Sun Aug 24 03:58:46 EDT 2025
Sat Aug 23 13:08:43 EDT 2025
Wed Feb 19 01:49:39 EST 2025
Mon Jul 21 09:11:59 EDT 2025
Thu Apr 24 23:06:08 EDT 2025
Tue Jul 01 02:55:26 EDT 2025
Fri Feb 21 02:25:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Obesity
Visceral adipose tissue
Inflammation
Gene expression
Lipocalin-2
Human
Adipose tissue
Enzyme
Nutrition disorder
Metalloendopeptidases
Biological activity
Gelatinase B
Gelatinase A
Medicine
Peptidases
Hydrolases
Metalloproteinase
Neutrophil gelatinase associated lipocalin
Nutritional status
Viscus
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-ab5cc236c985e1cb39d97f032a3075edbc0ed7bebe8abc5660395ce4c9dfdf1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 19466389
PQID 217684463
PQPubID 48876
PageCount 11
ParticipantIDs proquest_miscellaneous_67464661
proquest_miscellaneous_20146020
proquest_journals_217684463
pubmed_primary_19466389
pascalfrancis_primary_21766997
crossref_citationtrail_10_1007_s00109_009_0486_8
crossref_primary_10_1007_s00109_009_0486_8
springer_journals_10_1007_s00109_009_0486_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-08-01
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
– name: Germany
– name: New York
PublicationTitle Journal of molecular medicine (Berlin, Germany)
PublicationTitleAbbrev J Mol Med
PublicationTitleAlternate J Mol Med (Berl)
PublicationYear 2009
Publisher Springer-Verlag
Springer
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer
– name: Springer Nature B.V
References Van Gaal, Mertens, De Block (CR5) 2006; 444
Gómez-Ambrosi, Catalán, Ramírez, Rodríguez, Colina, Silva, Rotellar, Mugueta, Gil, Cienfuegos (CR45) 2007; 92
Greenberg, Obin (CR21) 2006; 83
Zhang, Wu, Zhang, Leroith, Bernlohr, Chen (CR14) 2008; 22
Catalán, Gómez-Ambrosi, Rodríguez, Silva, Rotellar, Gil, Cienfuegos, Salvador, Frühbeck (CR29) 2008; 68
Lai, Seshadri, Huang, Shao, Cai, Vattikuti, Schumacher, Loewy, Denhardt, Rittling (CR43) 2006; 98
Frühbeck, Gómez-Ambrosi, Muruzábal, Burrell (CR32) 2001; 280
Mori, Lee, Rapoport, Drexler, Foster, Yang, Schmidt-Ott, Chen, Li, Weiss (CR47) 2005; 115
Yan, Borregaard, Kjeldsen, Moses (CR24) 2001; 276
Fain, Buehrer, Bahouth, Tichansky, Madan (CR33) 2008; 57
Trayhurn (CR4) 2007; 8
Aigner, Maier, Schwelberger, Wallnofer, Amberger, Obrist, Berger, Mak, Maglione, Margreiter (CR18) 2007; 7
Shoelson, Herrero, Naaz (CR20) 2007; 132
Tan, Adya, Shan, Syed, Lewandowski, O'Hare, Randeva (CR15) 2009; 32
Christiaens, Scroyen, Lijnen (CR41) 2008; 99
Lin, Rajala, Berger, Moller, Barzilai, Scherer (CR17) 2001; 276
Bouloumié, Sengenès, Portolan, Galitzky, Lafontan (CR23) 2001; 50
Ginde, Geliebter, Rubiano, Silva, Wang, Heshka, Heymsfield (CR25) 2005; 13
Wajchenberg, Giannella-Neto, da Silva, Santos (CR36) 2002; 34
Frühbeck (CR7) 2008; 456
Hotamisligil, Shargill, Spiegelman (CR46) 1993; 259
Yang, Graham, Mody, Preitner, Peroni, Zabolotny, Kotani, Quadro, Kahn (CR34) 2005; 436
Rangaswami, Bulbule, Kundu (CR42) 2006; 16
Badman, Flier (CR1) 2007; 132
Rodríguez, Frühbeck, Gómez-Ambrosi, Catalán, Sáinz, Diez, Zalba, Fortuño (CR30) 2006; 24
Philip, Bulbule, Kundu (CR44) 2001; 276
Liu, Nilsen-Hamilton (CR11) 1995; 270
Hvidberg, Jacobsen, Strong, Cowland, Moestrup, Borregaard (CR40) 2005; 579
Sier, Kubben, Ganesh, Heerding, Griffioen, Hanemaaijer, van Krieken, Lamers, Verspaget (CR31) 1996; 74
Flo, Smith, Sato, Rodriguez, Holmes, Strong, Akira, Aderem (CR8) 2004; 432
Sethi, Vidal-Puig (CR6) 2007; 5
Yan, Yang, Mody, Graham, Hsu, Xu, Houstis, Kahn, Rosen (CR13) 2007; 56
Frühbeck, Gómez-Ambrosi (CR3) 2003; 46
Sommer, Weise, Kralisch, Lossner, Bluher, Stumvoll, Fasshauer (CR19) 2009; 106
Catalán, Gómez-Ambrosi, Rotellar, Silva, Rodríguez, Salvador, Gil, Cienfuegos, Frühbeck (CR28) 2007; 39
Stamenkovic (CR22) 2003; 200
Devireddy, Teodoro, Richard, Green (CR16) 2001; 293
Wang, Lam, Kraegen, Sweeney, Zhang, Tso, Chow, Wat, Xu, Hoo (CR12) 2007; 53
Devireddy, Gazin, Zhu, Green (CR9) 2005; 123
Gómez-Ambrosi, Catalán, Diez-Caballero, Martínez-Cruz, Gil, García-Foncillas, Cienfuegos, Salvador, Mato, Frühbeck (CR27) 2004; 18
Després, Lemieux (CR37) 2006; 444
Gómez-Ambrosi, Rodríguez, Catalán, Ramírez, Silva, Rotellar, Gil, Salvador, Frühbeck (CR35) 2008; 69
Catalán, Gómez-Ambrosi, Ramírez, Rotellar, Pastor, Silva, Rodríguez, Gil, Cienfuegos, Frühbeck (CR26) 2007; 17
Rodríguez, Catalán, Gómez-Ambrosi, Frühbeck (CR39) 2007; 13
Frühbeck, Gómez-Ambrosi (CR2) 2001; 15
Triebel, Blaser, Reinke, Tschesche (CR10) 1992; 314
Montague, Prins, Sanders, Zhang, Sewter, Digby, Byrne, O'Rahilly (CR38) 1998; 47
S Philip (486_CR44) 2001; 276
A Rodríguez (486_CR39) 2007; 13
JP Després (486_CR37) 2006; 444
G Frühbeck (486_CR2) 2001; 15
CF Lai (486_CR43) 2006; 98
Q Yang (486_CR34) 2005; 436
TH Flo (486_CR8) 2004; 432
G Frühbeck (486_CR7) 2008; 456
J Gómez-Ambrosi (486_CR45) 2007; 92
I Stamenkovic (486_CR22) 2003; 200
LF Gaal Van (486_CR5) 2006; 444
LR Devireddy (486_CR16) 2001; 293
V Catalán (486_CR26) 2007; 17
A Rodríguez (486_CR30) 2006; 24
P Trayhurn (486_CR4) 2007; 8
Y Lin (486_CR17) 2001; 276
J Gómez-Ambrosi (486_CR35) 2008; 69
MK Badman (486_CR1) 2007; 132
A Bouloumié (486_CR23) 2001; 50
V Hvidberg (486_CR40) 2005; 579
LR Devireddy (486_CR9) 2005; 123
V Christiaens (486_CR41) 2008; 99
L Yan (486_CR24) 2001; 276
K Mori (486_CR47) 2005; 115
G Sommer (486_CR19) 2009; 106
AS Greenberg (486_CR21) 2006; 83
H Rangaswami (486_CR42) 2006; 16
G Frühbeck (486_CR3) 2003; 46
BK Tan (486_CR15) 2009; 32
Q Liu (486_CR11) 1995; 270
G Frühbeck (486_CR32) 2001; 280
BL Wajchenberg (486_CR36) 2002; 34
V Catalán (486_CR29) 2008; 68
S Triebel (486_CR10) 1992; 314
V Catalán (486_CR28) 2007; 39
CF Sier (486_CR31) 1996; 74
SR Ginde (486_CR25) 2005; 13
J Gómez-Ambrosi (486_CR27) 2004; 18
CT Montague (486_CR38) 1998; 47
QW Yan (486_CR13) 2007; 56
SE Shoelson (486_CR20) 2007; 132
Y Wang (486_CR12) 2007; 53
JN Fain (486_CR33) 2008; 57
GS Hotamisligil (486_CR46) 1993; 259
JK Sethi (486_CR6) 2007; 5
F Aigner (486_CR18) 2007; 7
J Zhang (486_CR14) 2008; 22
18278177 - Thromb Haemost. 2008 Feb;99(2):290-4
8695357 - Br J Cancer. 1996 Aug;74(3):413-7
17498506 - Gastroenterology. 2007 May;132(6):2103-15
11522674 - Diabetes. 2001 Sep;50(9):2080-6
17639021 - Diabetes. 2007 Oct;56(10 ):2533-40
16877962 - J Hypertens. 2006 Aug;24(8):1589-97
16076993 - Obes Res. 2005 Jul;13(7):1232-7
15711640 - J Clin Invest. 2005 Mar;115(3):610-21
17040956 - Clin Chem. 2007 Jan;53(1):34-41
18852336 - Diabetes Care. 2009 Jan;32(1):129-31
15670845 - FEBS Lett. 2005 Jan 31;579(3):773-7
15531878 - Nature. 2004 Dec 16;432(7019):917-21
14630696 - FASEB J. 2004 Jan;18(1):215-7
11532980 - FASEB J. 2001 Sep;15(11):1996-2006
16377569 - Cell. 2005 Dec 29;123(7):1293-305
18292240 - Mol Endocrinol. 2008 Jun;22(6):1416-26
11350765 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E827-47
17498510 - Gastroenterology. 2007 May;132(6):2169-80
19009554 - J Cell Biochem. 2009 Jan 1;106(1):103-8
7545679 - J Biol Chem. 1995 Sep 22;270(38):22565-70
17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4
17595250 - J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27
17627548 - Curr Pharm Des. 2007;13(21):2169-75
12845612 - J Pathol. 2003 Jul;200(4):448-64
17803693 - Clin Endocrinol (Oxf). 2008 Feb;68(2):213-9
11486009 - J Biol Chem. 2001 Oct 5;276(40):37258-65
7678183 - Science. 1993 Jan 1;259(5091):87-91
11564733 - J Biol Chem. 2001 Nov 30;276(48):44926-35
16470013 - Am J Clin Nutr. 2006 Feb;83(2):461S-465S
11486081 - Science. 2001 Aug 3;293(5531):829-34
16709900 - Circ Res. 2006 Jun 23;98(12):1479-89
17391123 - Am J Transplant. 2007 Apr;7(4):779-88
12627314 - Diabetologia. 2003 Feb;46(2):143-72
17167477 - Nature. 2006 Dec 14;444(7121):881-7
18555844 - Metabolism. 2008 Jul;57(7):1005-15
17167476 - Nature. 2006 Dec 14;444(7121):875-80
18516549 - Methods Mol Biol. 2008;456:1-22
16406521 - Trends Cell Biol. 2006 Feb;16(2):79-87
18219773 - Obes Surg. 2007 Nov;17(11):1464-74
12660870 - Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21
17488634 - Cell Metab. 2007 May;5(5):323-5
17611901 - Horm Metab Res. 2007 Jul;39(7):495-500
1281792 - FEBS Lett. 1992 Dec 21;314(3):386-8
18081728 - Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15
16034410 - Nature. 2005 Jul 21;436(7049):356-62
11546817 - J Biol Chem. 2001 Nov 9;276(45):42077-83
9726225 - Diabetes. 1998 Sep;47(9):1384-91
References_xml – volume: 32
  start-page: 129
  year: 2009
  end-page: 131
  ident: CR15
  article-title: Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1236
– volume: 34
  start-page: 616
  year: 2002
  end-page: 621
  ident: CR36
  article-title: Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome
  publication-title: Horm Metab Res
  doi: 10.1055/s-2002-38256
– volume: 24
  start-page: 1589
  year: 2006
  end-page: 1597
  ident: CR30
  article-title: The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000239295.17636.6e
– volume: 13
  start-page: 1232
  year: 2005
  end-page: 1237
  ident: CR25
  article-title: Air displacement plethysmography: validation in overweight and obese subjects
  publication-title: Obes Res
  doi: 10.1038/oby.2005.146
– volume: 444
  start-page: 881
  year: 2006
  end-page: 887
  ident: CR37
  article-title: Abdominal obesity and metabolic syndrome
  publication-title: Nature
  doi: 10.1038/nature05488
– volume: 57
  start-page: 1005
  year: 2008
  end-page: 1015
  ident: CR33
  article-title: Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2008.02.019
– volume: 8
  start-page: 41
  issue: Suppl 1
  year: 2007
  end-page: 44
  ident: CR4
  article-title: Adipocyte biology
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2007.00316.x
– volume: 115
  start-page: 610
  year: 2005
  end-page: 621
  ident: CR47
  article-title: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury
  publication-title: J Clin Invest
– volume: 98
  start-page: 1479
  year: 2006
  end-page: 1489
  ident: CR43
  article-title: An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000227550.00426.60
– volume: 15
  start-page: 1996
  year: 2001
  end-page: 2006
  ident: CR2
  article-title: Rationale for the existence of additional adipostatic hormones
  publication-title: FASEB J
  doi: 10.1096/fj.00-0829hyp
– volume: 22
  start-page: 1416
  year: 2008
  end-page: 1426
  ident: CR14
  article-title: The role of lipocalin 2 in the regulation of inflammation in adipocytes and Macrophages
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2007-0420
– volume: 132
  start-page: 2169
  year: 2007
  end-page: 2180
  ident: CR20
  article-title: Obesity, inflammation, and insulin resistance
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.059
– volume: 46
  start-page: 143
  year: 2003
  end-page: 172
  ident: CR3
  article-title: Control of body weight: a physiologic and transgenic perspective
  publication-title: Diabetologia
– volume: 270
  start-page: 22565
  year: 1995
  end-page: 22570
  ident: CR11
  article-title: Identification of a new acute phase protein
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.38.22565
– volume: 276
  start-page: 42077
  year: 2001
  end-page: 42083
  ident: CR17
  article-title: Hyperglycemia-induced production of acute phase reactants in adipose tissue
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M107101200
– volume: 280
  start-page: E827
  year: 2001
  end-page: E847
  ident: CR32
  article-title: The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
  publication-title: Am J Physiol Endocrinol Metab
– volume: 56
  start-page: 2533
  year: 2007
  end-page: 2540
  ident: CR13
  article-title: The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance
  publication-title: Diabetes
  doi: 10.2337/db07-0007
– volume: 7
  start-page: 779
  year: 2007
  end-page: 788
  ident: CR18
  article-title: Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2006.01723.x
– volume: 18
  start-page: 215
  year: 2004
  end-page: 217
  ident: CR27
  article-title: Gene expression profile of omental adipose tissue in human obesity
  publication-title: FASEB J
– volume: 68
  start-page: 213
  year: 2008
  end-page: 219
  ident: CR29
  article-title: Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation
  publication-title: Clin Endocrinol
– volume: 83
  start-page: 461S
  year: 2006
  end-page: 465S
  ident: CR21
  article-title: Obesity and the role of adipose tissue in inflammation and metabolism
  publication-title: Am J Clin Nutr
– volume: 69
  start-page: 208
  year: 2008
  end-page: 215
  ident: CR35
  article-title: Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2007.03156.x
– volume: 47
  start-page: 1384
  year: 1998
  end-page: 1391
  ident: CR38
  article-title: Depot-related gene expression in human subcutaneous and omental adipocytes
  publication-title: Diabetes
  doi: 10.2337/diabetes.47.9.1384
– volume: 92
  start-page: 3719
  year: 2007
  end-page: 3727
  ident: CR45
  article-title: Plasma osteopontin levels and expression in adipose tissue are increased in obesity
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-0349
– volume: 106
  start-page: 103
  year: 2009
  end-page: 108
  ident: CR19
  article-title: Lipocalin-2 is induced by interleukin-1β in murine adipocytes in vitro
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.21980
– volume: 17
  start-page: 1464
  year: 2007
  end-page: 1474
  ident: CR26
  article-title: Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass
  publication-title: Obes Surg
  doi: 10.1007/s11695-008-9424-z
– volume: 200
  start-page: 448
  year: 2003
  end-page: 464
  ident: CR22
  article-title: Extracellular matrix remodeling: the role of matrix metalloproteinases
  publication-title: J Pathol
  doi: 10.1002/path.1400
– volume: 99
  start-page: 290
  year: 2008
  end-page: 294
  ident: CR41
  article-title: Role of proteolysis in development of murine adipose tissue
  publication-title: Thromb Haemost
– volume: 444
  start-page: 875
  year: 2006
  end-page: 880
  ident: CR5
  article-title: Mechanisms linking obesity with cardiovascular disease
  publication-title: Nature
  doi: 10.1038/nature05487
– volume: 432
  start-page: 917
  year: 2004
  end-page: 921
  ident: CR8
  article-title: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
  publication-title: Nature
  doi: 10.1038/nature03104
– volume: 50
  start-page: 2080
  year: 2001
  end-page: 2086
  ident: CR23
  article-title: Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.9.2080
– volume: 259
  start-page: 87
  year: 1993
  end-page: 91
  ident: CR46
  article-title: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance
  publication-title: Science
  doi: 10.1126/science.7678183
– volume: 5
  start-page: 323
  year: 2007
  end-page: 325
  ident: CR6
  article-title: Targeting fat to prevent diabetes
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2007.04.006
– volume: 456
  start-page: 1
  year: 2008
  end-page: 22
  ident: CR7
  article-title: Overview of adipose tissue and its role in obesity and metabolic disorders
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-245-8_1
– volume: 74
  start-page: 413
  year: 1996
  end-page: 417
  ident: CR31
  article-title: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
  publication-title: Br J Cancer
– volume: 436
  start-page: 356
  year: 2005
  end-page: 362
  ident: CR34
  article-title: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
  publication-title: Nature
  doi: 10.1038/nature03711
– volume: 132
  start-page: 2103
  year: 2007
  end-page: 2115
  ident: CR1
  article-title: The adipocyte as an active participant in energy balance and metabolism
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.058
– volume: 314
  start-page: 386
  year: 1992
  end-page: 388
  ident: CR10
  article-title: A 25 kDa α 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(92)81511-J
– volume: 39
  start-page: 495
  year: 2007
  end-page: 500
  ident: CR28
  article-title: Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus
  publication-title: Horm Metab Res
  doi: 10.1055/s-2007-982502
– volume: 276
  start-page: 44926
  year: 2001
  end-page: 44935
  ident: CR44
  article-title: Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κ B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M103334200
– volume: 293
  start-page: 829
  year: 2001
  end-page: 834
  ident: CR16
  article-title: Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation
  publication-title: Science
  doi: 10.1126/science.1061075
– volume: 276
  start-page: 37258
  year: 2001
  end-page: 37265
  ident: CR24
  article-title: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M106089200
– volume: 13
  start-page: 2169
  year: 2007
  end-page: 2175
  ident: CR39
  article-title: Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?
  publication-title: Curr Pharm Des
  doi: 10.2174/138161207781039599
– volume: 53
  start-page: 34
  year: 2007
  end-page: 41
  ident: CR12
  article-title: Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2006.075614
– volume: 123
  start-page: 1293
  year: 2005
  end-page: 1305
  ident: CR9
  article-title: A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake
  publication-title: Cell
  doi: 10.1016/j.cell.2005.10.027
– volume: 16
  start-page: 79
  year: 2006
  end-page: 87
  ident: CR42
  article-title: Osteopontin: role in cell signaling and cancer progression
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2005.12.005
– volume: 579
  start-page: 773
  year: 2005
  end-page: 777
  ident: CR40
  article-title: The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2004.12.031
– volume: 56
  start-page: 2533
  year: 2007
  ident: 486_CR13
  publication-title: Diabetes
  doi: 10.2337/db07-0007
– volume: 57
  start-page: 1005
  year: 2008
  ident: 486_CR33
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2008.02.019
– volume: 83
  start-page: 461S
  year: 2006
  ident: 486_CR21
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/83.2.461S
– volume: 259
  start-page: 87
  year: 1993
  ident: 486_CR46
  publication-title: Science
  doi: 10.1126/science.7678183
– volume: 8
  start-page: 41
  issue: Suppl 1
  year: 2007
  ident: 486_CR4
  publication-title: Obes Rev
  doi: 10.1111/j.1467-789X.2007.00316.x
– volume: 47
  start-page: 1384
  year: 1998
  ident: 486_CR38
  publication-title: Diabetes
  doi: 10.2337/diabetes.47.9.1384
– volume: 276
  start-page: 37258
  year: 2001
  ident: 486_CR24
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M106089200
– volume: 68
  start-page: 213
  year: 2008
  ident: 486_CR29
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2007.03021.x
– volume: 270
  start-page: 22565
  year: 1995
  ident: 486_CR11
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.38.22565
– volume: 200
  start-page: 448
  year: 2003
  ident: 486_CR22
  publication-title: J Pathol
  doi: 10.1002/path.1400
– volume: 579
  start-page: 773
  year: 2005
  ident: 486_CR40
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2004.12.031
– volume: 132
  start-page: 2103
  year: 2007
  ident: 486_CR1
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.058
– volume: 132
  start-page: 2169
  year: 2007
  ident: 486_CR20
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.059
– volume: 74
  start-page: 413
  year: 1996
  ident: 486_CR31
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1996.374
– volume: 34
  start-page: 616
  year: 2002
  ident: 486_CR36
  publication-title: Horm Metab Res
  doi: 10.1055/s-2002-38256
– volume: 16
  start-page: 79
  year: 2006
  ident: 486_CR42
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2005.12.005
– volume: 69
  start-page: 208
  year: 2008
  ident: 486_CR35
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2007.03156.x
– volume: 13
  start-page: 1232
  year: 2005
  ident: 486_CR25
  publication-title: Obes Res
  doi: 10.1038/oby.2005.146
– volume: 39
  start-page: 495
  year: 2007
  ident: 486_CR28
  publication-title: Horm Metab Res
  doi: 10.1055/s-2007-982502
– volume: 7
  start-page: 779
  year: 2007
  ident: 486_CR18
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2006.01723.x
– volume: 106
  start-page: 103
  year: 2009
  ident: 486_CR19
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.21980
– volume: 314
  start-page: 386
  year: 1992
  ident: 486_CR10
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(92)81511-J
– volume: 276
  start-page: 42077
  year: 2001
  ident: 486_CR17
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M107101200
– volume: 46
  start-page: 143
  year: 2003
  ident: 486_CR3
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1053-4
– volume: 50
  start-page: 2080
  year: 2001
  ident: 486_CR23
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.9.2080
– volume: 24
  start-page: 1589
  year: 2006
  ident: 486_CR30
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000239295.17636.6e
– volume: 92
  start-page: 3719
  year: 2007
  ident: 486_CR45
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-0349
– volume: 32
  start-page: 129
  year: 2009
  ident: 486_CR15
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1236
– volume: 18
  start-page: 215
  year: 2004
  ident: 486_CR27
  publication-title: FASEB J
  doi: 10.1096/fj.03-0591fje
– volume: 98
  start-page: 1479
  year: 2006
  ident: 486_CR43
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000227550.00426.60
– volume: 15
  start-page: 1996
  year: 2001
  ident: 486_CR2
  publication-title: FASEB J
  doi: 10.1096/fj.00-0829hyp
– volume: 456
  start-page: 1
  year: 2008
  ident: 486_CR7
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-245-8_1
– volume: 276
  start-page: 44926
  year: 2001
  ident: 486_CR44
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M103334200
– volume: 115
  start-page: 610
  year: 2005
  ident: 486_CR47
  publication-title: J Clin Invest
  doi: 10.1172/JCI23056
– volume: 5
  start-page: 323
  year: 2007
  ident: 486_CR6
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2007.04.006
– volume: 436
  start-page: 356
  year: 2005
  ident: 486_CR34
  publication-title: Nature
  doi: 10.1038/nature03711
– volume: 13
  start-page: 2169
  year: 2007
  ident: 486_CR39
  publication-title: Curr Pharm Des
  doi: 10.2174/138161207781039599
– volume: 53
  start-page: 34
  year: 2007
  ident: 486_CR12
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2006.075614
– volume: 293
  start-page: 829
  year: 2001
  ident: 486_CR16
  publication-title: Science
  doi: 10.1126/science.1061075
– volume: 444
  start-page: 875
  year: 2006
  ident: 486_CR5
  publication-title: Nature
  doi: 10.1038/nature05487
– volume: 99
  start-page: 290
  year: 2008
  ident: 486_CR41
  publication-title: Thromb Haemost
  doi: 10.1160/TH07-10-0589
– volume: 17
  start-page: 1464
  year: 2007
  ident: 486_CR26
  publication-title: Obes Surg
  doi: 10.1007/s11695-008-9424-z
– volume: 22
  start-page: 1416
  year: 2008
  ident: 486_CR14
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2007-0420
– volume: 432
  start-page: 917
  year: 2004
  ident: 486_CR8
  publication-title: Nature
  doi: 10.1038/nature03104
– volume: 280
  start-page: E827
  year: 2001
  ident: 486_CR32
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.2001.280.6.E827
– volume: 123
  start-page: 1293
  year: 2005
  ident: 486_CR9
  publication-title: Cell
  doi: 10.1016/j.cell.2005.10.027
– volume: 444
  start-page: 881
  year: 2006
  ident: 486_CR37
  publication-title: Nature
  doi: 10.1038/nature05488
– reference: 18219773 - Obes Surg. 2007 Nov;17(11):1464-74
– reference: 16034410 - Nature. 2005 Jul 21;436(7049):356-62
– reference: 18292240 - Mol Endocrinol. 2008 Jun;22(6):1416-26
– reference: 11486081 - Science. 2001 Aug 3;293(5531):829-34
– reference: 17498506 - Gastroenterology. 2007 May;132(6):2103-15
– reference: 11564733 - J Biol Chem. 2001 Nov 30;276(48):44926-35
– reference: 16076993 - Obes Res. 2005 Jul;13(7):1232-7
– reference: 12845612 - J Pathol. 2003 Jul;200(4):448-64
– reference: 11522674 - Diabetes. 2001 Sep;50(9):2080-6
– reference: 18852336 - Diabetes Care. 2009 Jan;32(1):129-31
– reference: 11546817 - J Biol Chem. 2001 Nov 9;276(45):42077-83
– reference: 9726225 - Diabetes. 1998 Sep;47(9):1384-91
– reference: 17040956 - Clin Chem. 2007 Jan;53(1):34-41
– reference: 11350765 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E827-47
– reference: 16470013 - Am J Clin Nutr. 2006 Feb;83(2):461S-465S
– reference: 16406521 - Trends Cell Biol. 2006 Feb;16(2):79-87
– reference: 15670845 - FEBS Lett. 2005 Jan 31;579(3):773-7
– reference: 16709900 - Circ Res. 2006 Jun 23;98(12):1479-89
– reference: 14630696 - FASEB J. 2004 Jan;18(1):215-7
– reference: 12627314 - Diabetologia. 2003 Feb;46(2):143-72
– reference: 18081728 - Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15
– reference: 18516549 - Methods Mol Biol. 2008;456:1-22
– reference: 17167477 - Nature. 2006 Dec 14;444(7121):881-7
– reference: 12660870 - Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21
– reference: 17611901 - Horm Metab Res. 2007 Jul;39(7):495-500
– reference: 11486009 - J Biol Chem. 2001 Oct 5;276(40):37258-65
– reference: 17639021 - Diabetes. 2007 Oct;56(10 ):2533-40
– reference: 16377569 - Cell. 2005 Dec 29;123(7):1293-305
– reference: 17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4
– reference: 17803693 - Clin Endocrinol (Oxf). 2008 Feb;68(2):213-9
– reference: 17498510 - Gastroenterology. 2007 May;132(6):2169-80
– reference: 1281792 - FEBS Lett. 1992 Dec 21;314(3):386-8
– reference: 17627548 - Curr Pharm Des. 2007;13(21):2169-75
– reference: 17488634 - Cell Metab. 2007 May;5(5):323-5
– reference: 8695357 - Br J Cancer. 1996 Aug;74(3):413-7
– reference: 17595250 - J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27
– reference: 11532980 - FASEB J. 2001 Sep;15(11):1996-2006
– reference: 17391123 - Am J Transplant. 2007 Apr;7(4):779-88
– reference: 18555844 - Metabolism. 2008 Jul;57(7):1005-15
– reference: 7678183 - Science. 1993 Jan 1;259(5091):87-91
– reference: 16877962 - J Hypertens. 2006 Aug;24(8):1589-97
– reference: 19009554 - J Cell Biochem. 2009 Jan 1;106(1):103-8
– reference: 17167476 - Nature. 2006 Dec 14;444(7121):875-80
– reference: 15711640 - J Clin Invest. 2005 Mar;115(3):610-21
– reference: 18278177 - Thromb Haemost. 2008 Feb;99(2):290-4
– reference: 15531878 - Nature. 2004 Dec 16;432(7019):917-21
– reference: 7545679 - J Biol Chem. 1995 Sep 22;270(38):22565-70
SSID ssj0017594
Score 2.3612156
Snippet Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the...
SourceID proquest
pubmed
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 803
SubjectTerms Acute-Phase Proteins - genetics
Acute-Phase Proteins - metabolism
Adult
Antigens, CD - genetics
Antigens, CD - metabolism
Antigens, Differentiation, Myelomonocytic - genetics
Antigens, Differentiation, Myelomonocytic - metabolism
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Body fat
Female
Gene Expression Regulation
General aspects
Human Genetics
Humans
Internal Medicine
Intra-Abdominal Fat - metabolism
Lipocalin-2
Lipocalins - blood
Lipocalins - genetics
Lipocalins - metabolism
Male
Matrix Metalloproteinase 2 - blood
Matrix Metalloproteinase 2 - genetics
Matrix Metalloproteinase 2 - metabolism
Matrix Metalloproteinase 9 - blood
Matrix Metalloproteinase 9 - genetics
Matrix Metalloproteinase 9 - metabolism
Medical sciences
Metabolic diseases
Molecular Medicine
Obesity
Obesity - genetics
Obesity - metabolism
Obesity - physiopathology
Original Article
Osteopontin - genetics
Osteopontin - metabolism
Protein Binding
Proto-Oncogene Proteins - blood
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
RNA, Messenger - genetics
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - metabolism
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Lat0wEB3aFEqhlKZPN02qRVctAluybGkZSkMIJKteyM7oCYbEvsROyQf1QzuSHyEkKXThjUeyZM_InvHRnAH46lVQOXM5BjlC0tIWJZW68LTQuUPvXwTj4n_I07PqeFOenIvzOY97WHa7L5BkelOvyW4JxaHTz3xZUfkUnokYuqMRb9jhCh3UIlU_xLClogyjgQXKfOgSdz5GL7d6wOcSpoIWD3mc99DS9BE6eg2vZu-RHE7q3oUnvnsDz09nfPwt_MHlHneZe0e0a7f94MmYnizxN_OO1470gVygDCfRdpSRFs9M1QFIO5CU24Ldxx4FAc1lSm0kunPkMtL535BLP0a0PjE8tB0OhhdJ4nvnFYlpE78TaWscJxUEHN7B5ujnrx_HdK7DQG2pqpFqI6xlvLJKCl9Yw5VTdcg50_iCEN4Zm3tXGzQHqY1F_zDnSlhfWuWCC4Xn72Gn6zv_EUilhJQFLwwLrOSWa-uMRK8IO3LuZJFBviiksTNJeayVcdGs9MpJh00eD9RhIzP4tnbZTgwd_2p8cEfLaw8WiTKVqjPYW9TezKt5SEKJcTPP4MsqxWUYsRXd-f4am0QSHnS9H29R1WVVojeUwYfJmm5nGzn-0XHM4PtiXrdjP3orn_6r9R68mHCwuHXxM-yMV9d-H92p0Ryk5fMXMa0Z1Q
  priority: 102
  providerName: Springer Nature
Title Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans
URI https://link.springer.com/article/10.1007/s00109-009-0486-8
https://www.ncbi.nlm.nih.gov/pubmed/19466389
https://www.proquest.com/docview/217684463
https://www.proquest.com/docview/20146020
https://www.proquest.com/docview/67464661
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_agggifrtWzzz4pAQ3m91s8iSnXC1Ki4gH59OSTbKw0O6e3W3pH-Qf6kz2o5TaPhwH-bjkdibJb3YmvyHkndeVjhMXg5GTKZZanjJluGfcxA7Qf1aVDt9DHh7Jg3X6bZNtxticbgyrnPbEsFG71uI78o8AnaUC20V82v5hmDQKnatjBo27ZBeZyzCiK9_M9hYcjCEPIhgwkiVgF0xOzThwiHL0CgTPgJJMXTmWHmxNB0-oGlJb_A97XvObhuNo_xF5OOJIuhwE_5jc8c0Tcu9w9JQ_JX9h4WO8uXfUuHrbdp724RlTfzHGvja0regx1MEk6oYltIaSIU8ArTsabrlA976FigoUZ7jkSE3j6AkS-1_QE9-j3z5wPdQNDAY_EqqvlWuKFyjOA30rjhNSA3bPyHp_9evLARszMjCbatkzU2bWJkJarTLPbSm003kVi8TAVpF5V9rYu7wExVCmtIAUY6Ez61OrXeUq7sVzstO0jX9JqAR5KS54mVRJKqww1pUK8BF0FMIpHpF4EkhhR7pyzJpxXMxEy0GGRYwfkGGhIvJ-7rIduDpua7y4IuW5Byqa1DqPyN4k9mJc110xa2FE3s61sCDRy2Ia355BE6TjARB-cwuZpzIFXBSRF4M2Xc4W2f4BQkbkw6Rel2Pf-Fde3TrTPXJ_8IBh0OJrstOfnvk3AKT6chGWy4LsLr_-_r6C78-rox8_oXSdLP8BSsohAw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRICPEmFFof4AKySOLEax8Q4tFqS7srhFqpt9SxHSlSmywkhfJ_uPIfGTuPqirtrYdcYjt2NJPJN57xfAAvrSxkGJsQnZxU0ERHCRUqsjRSoUH0nxa5cfuQ8wWf7SdfDtKDFfg7nIVxaZWDTfSG2tTa7ZG_RejMBfou7P3yO3WkUS64OjBodFqxY3__Qo-tebf9GcX7Ko63Nvc-zWhPKkB1InlLVZ5qHTOupUhtpHMmjZwWIYsVantqTa5Da6Y5vptQuUawEzKZaptoaQpTRJbhc2_AasLQk5nA6sfNxddvY9himnrmRXSZOI3RExnCqKGvWhq5OISPRQhOxbkf4Z2lalAmRUem8T-0eyFS63-AW_fgbo9cyYdO1e7Diq0ewM15H5t_CH_Q1LgMd2uIMuWybixpvVSJPe2zbStSF-QI23ARZUVjUuKdjpmAlA3x52pweFtjQ4Gq2h2rJKoy5NhRCZySY9u6TAFfXaKscDJ8iG--cF8Sd2Tjpy8Y6-bxZITNI9i_FnE9hklVV_YpEC5TISIW5XERJ0wzpU0uEJHhQMaMiAIIB4Fkui-Q7ng6jrKxtLOXYRa6C2WYiQBej0OWXXWQqzqvn5PyOMKpNpdyGsDaIPastyRNNup9ABtjK5oAF9dRla1PsIsrAISw__IefJrwBJFYAE86bTpbreMXQNAawJtBvc7mvvRVnl250g24Ndub72a724udNbjdxd9cyuRzmLQ_TuwLhHFtvt5_PAQOr_t7_QcOgl4B
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9UwEB6VIlVICLGWUGh9gAvIahxnsQ8IIcpTS2nFgUrvFhwv0pPa5EFSKP-HP8G_Y-wsVVXaWw-5xHbsaBbPeMbzAby00sk4MTE6OZmgqWYpFYpZylRs0PrPXGX8OeTBYb57lH6aZ_MV-DvehfFplaNODIraNNqfkW-j6ZwL9F34thuyIr7szN4tv1MPIOUDrSOaRs8h-_b3L_Te2rd7O0jqV0ky-_j1wy4dAAaoTmXeUVVlWic811JklumKSyMLF_NEIedn1lQ6tqao8D-FqjQaPjGXmbaplsYZxyzH796C2wXPmBexYj75ergpBwxGdJ5ymqBPMgZU41C_lPmIRIhKiJyKC1vi3aVqkTquh9X4n917KWYbtsLZfbg32LDkfc90D2DF1g9h7WCI0j-CP6h0fK67NUSZxbJpLekCfYk9G_Jua9I4coxtuIhFTROywDc9RgFZtCTcsMHhXYMNDpm2v2BJVG3IiQcVOCMntvM5A6HOxKLGyfAjofnSe0n85Y2foXSsnyfAEraP4ehGiPUEVuumtk-B5DITgnFWJS5JueZKm0qgbYYDOTeCRRCPBCn1UCrdI3Ycl1OR50DDMvYP0rAUEbyehiz7OiHXdd68QOVphGfyXMoigo2R7OWgU9pykoAItqZWVAY-wqNq25xiF18KCB2Aq3vkRZqnaJNFsN5z0_lqPdIAmq8RvBnZ63zuK3_l2bUr3YI1lNLy897h_gbc6QNxPnfyOax2P07tC7TnumozSA6Bbzctqv8ARsFg0Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+adipose+tissue+expression+of+lipocalin-2+in+obesity+is+related+to+inflammation+and+matrix+metalloproteinase-2+and+metalloproteinase-9+activities+in+humans&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Catal%C3%A1n%2C+V&rft.au=G%C3%B3mez-Ambrosi%2C+J&rft.au=Rodr%C3%ADguez%2C+A&rft.au=Ram%C3%ADrez%2C+B&rft.date=2009-08-01&rft.eissn=1432-1440&rft.volume=87&rft.issue=8&rft.spage=803&rft.epage=813&rft_id=info:doi/10.1007%2Fs00109-009-0486-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon